Related Experiment Video
Updated: Jan 15, 2026

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
Published on: March 29, 2024
Characteristics of lipid metabolism dysfunction in hypertensive disorders of pregnancy
Zizhuo Wang1,2, Liangnan Zhang1,2, Xuan Zhou1,2
1National Clinical Research Center for Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
Insights
Hypertensive disorders of pregnancy (HDP) show altered lipid metabolism, especially fatty acids (FAs), linked to clinical features. MCAM and MAPK pathways may play roles in HDP pathogenesis.
Area of Science:
- Obstetrics and Gynecology
- Metabolomics
- Molecular Biology
Background:
- Hypertensive disorders of pregnancy (HDP) are major causes of maternal and perinatal morbidity.
- Lipid metabolism dysfunction is implicated in HDP, but its specific characteristics are unclear.
Purpose of the Study:
- To investigate lipid metabolism dysfunction in HDP.
- To identify molecular pathways involved in HDP-related lipid dysregulation.
Main Methods:
- Full-spectrum metabolomic profiling of blood samples from 30 HDP patients and 30 controls.
- Targeted metabolic validation in placental tissues.
- RNA sequencing to analyze gene expression related to lipid metabolism.
Main Results:
- Significant disruptions in fatty acyl (FA) metabolism observed in HDP patients.
- Specific FA levels correlated with HDP clinical characteristics.
- MCAM expression linked to FA metabolism and HDP symptoms; MAPK pathway activation suggested.
Conclusions:
- Provides insights into lipid metabolism dysfunction in HDP.
- Delineates potential molecular pathways involving MCAM and MAPK in HDP pathogenesis.
Background:
Hypertensive disorders of pregnancy (HDP) rank among the primary contributors to maternal and perinatal morbidity, characterized by hypertension, proteinuria, and neuropsychiatric manifestations. While metabolic dysfunction is recognized as a driving factor in various diseases, the precise characteristics of lipid metabolism dysfunction in HDP remain inadequately understood.
Methods:
Full-spectrum metabolomic profiling was performed on peripheral blood samples from 30 patients with HDP and 30 healthy controls, with targeted metabolic validation using placental tissues. RNA sequencing was employed to investigate the molecular characteristics underlying lipid metabolism dysregulation in HDP.
Results:
Our findings highlight significant disruptions in lipid metabolism, particularly fatty acyls (FAs), in patients with HDP. The levels of specific FAs were closely associated with HDP clinical characteristics. Furthermore, RNA sequencing revealed a strong correlation between MCAM expression and FA metabolism, as well as HDP-related symptoms. KEGG pathway analysis and molecular biology experiments suggested the activation of MAPK pathway may be related with MCAM's involvement in FA metabolism among patients with HDP.
Conclusions:
Our study provides insights into the characteristics of lipid metabolism dysfunction in HDP and delineates its potential molecular pathways.
More Related Videos
Related Concept Videos
Hypertension II: Pathophysiology
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Hypertension III: Clinical Manifestations and Diagnostic Studies
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Hormonal Regulation
Hypertension I: Introduction

